Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.
about
Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling studyFluad®-MF59®-Adjuvanted Influenza Vaccine in Older AdultsInfluenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaquesEffectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 yearsEffectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013.Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewField seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza seasonVaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 SeasonApplication of the screening method to monitor influenza vaccine effectiveness among the elderly in GermanyEffectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study.The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis.Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review.Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.Social class based on occupation is associated with hospitalization for A(H1N1)pdm09 infection. Comparison between hospitalized and ambulatory cases.Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren).Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza
P2860
Q21144595-5911A5A6-EB9C-4A6B-90D5-F69B10E9F1FCQ27009478-C786C90E-F0A7-4F74-848F-4B5043C29FD9Q30383312-FD2AD754-28D4-4C9E-BCD5-C149C875FA48Q30401497-17A8587F-1F14-4A10-A775-E79AE7CF3D10Q30427950-2359EEA9-7F23-493D-A557-96614E07916DQ34274852-37336BC5-DB22-4FE9-ADD5-0815079E0069Q34274933-74F2E296-7FAD-4EA3-BDD8-7E3843101F59Q34778408-B1CCAC67-AC26-46C9-A1E2-2A69112CB4B1Q34786909-A5756196-98B5-4866-A2B7-4FB1F43D999AQ35097579-71DC2982-72BF-4588-8A94-6DC56E5D9FDBQ35211657-9637A302-B462-4B12-B07B-844486C69DCDQ36251706-5A864F8B-8BD2-44E1-9191-E46C430086DDQ38639994-7D6305CE-D13F-4964-9548-A199769BB772Q38660898-A98A29E9-6872-46AE-BE50-6071DC2E7517Q38819920-FE3E48DC-CFCD-445A-BCA7-6AD47BF30F84Q39340731-8D412022-09A9-4A83-8114-D50CD497A0E0Q39530697-C27B864E-048D-4D67-A995-88071C3BEB6DQ41053372-1FFE8B85-4302-4DFB-A542-EB40717CEA5DQ52845428-71E1DB04-48E7-473F-9042-4E64784B9455Q56791503-AF612547-319B-4695-A9FE-B33B8AB90D92
P2860
Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@ast
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@en
type
label
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@ast
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@en
prefLabel
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@ast
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@en
P2093
P2860
P1476
Age-specific vaccine effective ...... fluenza in the United Kingdom.
@en
P2093
C Robertson
D M Fleming
D Rh Thomas
J M Watson
J McMenamin
P2860
P304
P356
10.1017/S0950268812001148
P577
2012-06-13T00:00:00Z